18-11-2021||Today's||The limits of the Gandhi-Khurshid strategy||In this age of social media outrage, prime time noise and WhatsApp forwards, every word spoken or written in the public domain travels across the universe in real time at supersonic speed. The Bharatiya Janata Party (BJP)’s vast social media army, in particular, has mastered the art of latching onto even the slightest slip by its political opponents to create a storm in cyberspace and beyond. The latest example is the response to Congress leader Salman Khurshid’s book on the Ayodhya judgment, which has one sentence drawing a parallel between a “robust version” of political Hindutva and the jihadist Islam of terror groups such as Islamic State and Boko Haram.
18-11-2021||Today's||For clean air, get citizens involved||With the onset of winter, the Indo-Gangetic plain is, once again, enveloped in thick smoke. While Delhi is at the centre of the discourse on air pollution, the clamour for clean air is gaining traction across the country.
18-11-2021||Today's||Behind the facade of civility, the reality of the US-China dialogue||The leaders of the two most consequential global powers have finally found time to have a virtual summit. United States (US) President Joe Biden and Chinese President Xi Jinping had their much-awaited summit this week and indulged each other, with neither side revealing its diplomatic cards fully.
18-11-2021||Today's||The race for the domination of AI chips||With the emergence of new applications of semiconductors, the concept of using artificial intelligence (AI) algorithms on high-end chipsets has opened an entirely new market for these devices, also known as AI chips.
18-11-2021||Today's||Scientifically Speaking | The consequence of excluding women from drug trials||Adverse drug reactions are unwanted, harmful effects of taking drugs. In the United States (US) alone, where the Food and Drug Administration (FDA) documents these effects, they are the fourth leading cause of death. Around half of these adverse reactions may be preventable. But often the risks are not known because diverse populations were not included in clinical trials that led to the approval of these drugs.
